Lantheus Holdings, Inc. Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
Lantheus Holdings, Inc. (LNTH) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $2.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-06
- Lantheus Holdings, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-06-30 was $2.10M, a 118.28% increase year-over-year.
- Lantheus Holdings, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-03-31 was $15.70M, a 33.74% decline year-over-year.
- Lantheus Holdings, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-09-30 was $591.00K, a 54.95% decline year-over-year.
- Lantheus Holdings, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-06-30 was $963.00K, a 4.22% increase year-over-year.
- Lantheus Holdings, Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2025 was $26.34M, a 16.46% increase from fiscal 2024.
- Lantheus Holdings, Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2024 was $22.61M, a 57.11% increase from fiscal 2023.
- Lantheus Holdings, Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2023 was $14.39M, a 85.51% increase from fiscal 2022.
- Lantheus Holdings, Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2022 was $7.76M, a 279.23% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 9 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.10M 10-Q · filed 2026-08-06 | $17.80M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $15.70M 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $26.34M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $591.00K 10-Q · filed 2025-11-06 | $1.55M derived: sum of 2 quarters · filed 2026-08-06 | $25.24M derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-06-30 | $963.00K 10-Q · filed 2026-08-06 | $24.65M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $23.69M 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | $22.61M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $1.31M 10-Q · filed 2025-11-06 | $2.24M derived: sum of 2 quarters · filed 2025-11-06 | $21.65M derived: sum of 3 quarters · filed 2025-11-06 | |
| 2024-06-30 | $924.00K 10-Q · filed 2025-11-06 | $20.34M derived: sum of 2 quarters · filed 2025-11-06 | ||
| 2024-03-31 | $19.42M 10-Q · filed 2025-11-06 | |||
| 2023-12-31 | $14.39M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $1.00M 10-Q · filed 2024-11-06 | $2.47M derived: sum of 2 quarters · filed 2024-11-06 | $13.62M derived: sum of 3 quarters · filed 2024-11-06 | |
| 2023-06-30 | $1.47M 10-Q · filed 2024-11-06 | $12.62M derived: sum of 2 quarters · filed 2024-11-06 | ||
| 2023-03-31 | $11.15M 10-Q · filed 2024-11-06 | |||
| 2022-12-31 | $7.76M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | $843.00K 10-Q · filed 2023-11-02 | $1.67M derived: sum of 2 quarters · filed 2023-11-02 | $7.17M derived: sum of 3 quarters · filed 2023-11-02 | |
| 2022-06-30 | $824.00K 10-Q · filed 2023-11-02 | $6.33M derived: sum of 2 quarters · filed 2023-11-02 | ||
| 2022-03-31 | $5.50M 10-Q · filed 2023-11-02 | |||
| 2021-12-31 | $2.05M 10-K · filed 2024-02-22 | |||
| 2021-09-30 | $67.00K 10-Q · filed 2022-11-03 | $260.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.86M derived: sum of 3 quarters · filed 2022-11-03 | |
| 2021-06-30 | $193.00K 10-Q · filed 2022-11-03 | $1.79M derived: sum of 2 quarters · filed 2022-11-03 | ||
| 2021-03-31 | $1.60M 10-Q · filed 2022-11-03 | |||
| 2020-12-31 | $2.13M 10-K · filed 2023-02-23 | |||
| 2020-09-30 | $50.00K 10-Q · filed 2021-11-04 | $535.00K derived: sum of 2 quarters · filed 2021-11-04 | $2.08M derived: sum of 3 quarters · filed 2021-11-04 | |
| 2020-06-30 | $485.00K 10-Q · filed 2021-11-04 | $2.03M derived: sum of 2 quarters · filed 2021-11-04 | ||
| 2020-03-31 | $1.55M 10-Q · filed 2021-11-04 | |||
| 2019-12-31 | $2.45M 10-K · filed 2022-02-24 | |||
| 2019-09-30 | $347.00K 10-Q · filed 2020-11-05 | $1.29M derived: sum of 2 quarters · filed 2020-11-05 | $2.41M derived: sum of 3 quarters · filed 2020-11-05 | |
| 2019-06-30 | $944.00K 10-Q · filed 2020-11-05 | $2.06M derived: sum of 2 quarters · filed 2020-11-05 | ||
| 2019-03-31 | $1.12M 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | $3.39M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $933.00K 10-Q · filed 2019-10-31 | $2.65M derived: sum of 2 quarters · filed 2019-10-31 | $3.36M derived: sum of 3 quarters · filed 2019-10-31 | |
| 2018-06-30 | $1.72M 10-Q · filed 2019-10-31 | $2.43M derived: sum of 2 quarters · filed 2019-10-31 | ||
| 2018-03-31 | $709.00K 10-Q · filed 2019-10-31 | |||
| 2017-12-31 | $2.85M 10-K · filed 2020-02-25 | |||
| 2016-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $602.00K 10-K · filed 2019-02-20 | ||
| 2016-09-30 | $552.00K 10-Q · filed 2016-11-01 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $97.00K 10-K · filed 2018-02-26 | ||
| 2015-09-30 | $97.00K 10-Q · filed 2015-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |